Lactose (India) Ltd. shows significantly poorer performance metrics compared to its peers, with zero growth and profitability indicators. This positions it as a laggard in a competitive pharmaceuticals sector that boasts companies with robust growth, strong profitability, and reasonable valuations.

• • Lactose (India) Ltd. has no revenue growth, EPS, or profitability metrics.
• • Top peers like Sun Pharma and Cipla show strong revenue growth and profitability, while Lactose struggles significantly.
• • Valuation metrics for Lactose indicate overvaluation compared to its lack of growth and profitability.